Immunomonitoring des lymphocytes T an

Immunomonitoring*des*lymphocytes*T**
an56tumoraux*:**
biomarqueurs*des*immunothérapies*?=
!"#$%&'()%(*"#+"&,'-(!.(/,.(
0"1'#"2'3#%()456678'&'93%(
:"$7&2;()%(!;)%$38%(%2(*<=>()%(?"8$@(
5!A/B(>!=(CDEF(*?=GH>83+(0'##"38%(
(

!"#"$%&'()*('"(+",-."$%)(/%("0122" !#"3,'4(5."6,+7'("0128"
9,/%('":;%(-,*-("%-)/)<7(=(/+">"
?"@7(''("A"B(':7("B,'"-(""
C5C+D=(")==7/)+,)'("

0I(6;6'3#%J(JK;$3LM7%J()%J("8N9O8%J(276'#"7P(
• Q($3$"2#3$%J()%(97%##%(R-(0I(Q(;K73J;J(R-()3S$7&2;J(K'7#(&%7#(
3)%8NL$"N'8(TU"31&%(U#;M7%8$%-($%&&7&%J()@JU'8$N'88%&&%JV(

Pronos5c*favorable*si*LT*mémoires*détectables=
• !%3&&%7#(J7#+3%("K#OJ($,363'2,;#"K3%(J3(K#;J%8$%()%J(&@6K,'$@2%J(*.WX("8NH
2;&'6;#"J%("+"82(&%(2#"32%6%82(TY')%2(Z(et#al-(*&38(*"8$%#(=%J([\][V(
• !%3&&%7#(J7#+3%()7(6;&"8'6%(J3(K#;J%8$%()%(&@6K,'$@2%J(I("8NH?ZH^GAH]('7(
!%&"8HB(T_%3)%(`(et#al-(a(*&38(A8$'&([\][V(
(

Immunothérapies**
«*checkpoint*blockade*»=
• I#OJ(K#'6%b%7J%J-(#;J7&2"2J(2#OJ(36K#%JJ3'88"82J()"8J(
)3c;#%82J(2@K%J()%($"8$%#(
• B8N$'#KJ("8NH/.H]-("8NH/.0H]-("8NH*I0BHW(
• ^S$"$32;(+"#3"1&%(
• dD\HF\e()%J(K"N%82J(#;K'8)%82(
• ^PK#%JJ3'8()%(/.0H](K"#(&%J($%&&7&%J(276'#"&%Jf(
• /#;J%8$%()478%(#;K'8J%(36678%("8NH$"8$%#((
K#;"&"1&%("7(2#"32%6%82(T_'&$,'g(a.-(?"27#%([\]WV(
(
(
• E=BF'+,/%(":7"=F/)+F')/@":("%(C"';BF/C(C""
G<7,/+)H%,IF/J"%,',%+;')C,IF/K">""
%F'';-,+C":L(M%,%)+;J"%F=B';&(/C)F/":(C"=;%,/)C=(CJ"C7)4)"
6B1J(
!#"3,'4(5."6,+7'("0128"